icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
EFFECT OF LONG TERM VIRAL SUPPRESSION WITH SOFOSBUVIR + RIBAVIRIN ON HEPATIC VENOUS PRESSURE GRADIENT IN HCV-INFECTED PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Nezam Afdhal* 1, Gregory T. Everson2, Jose Luis Calleja3, Geoffrey McCaughan4, Jaime Bosch5, Jill Denning6, Diana M. Brainard6, John G. McHutchison6, Theo Brandt-Sarif6, Di An6, Michael Charlton7, K. R. Reddy8, Tarik Asselah9, Edward Gane10, Xavier Forns5
1Beth Israel Deaconess Medical Center, Boston, 2University of Colorado Denver, Aurora, United States, 3Hospital Puerta de Hierro, Madrid, Spain, 4Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia, 5Liver Unit, IDIBAPS, CIBEREHD, Barcelona, Spain, 6Gilead Sciences, Inc., Foster City, 7Intermountain Medical Center, Murray, 8University of Pennsylvania School of Medicine, Philadelphia, United States, 9Hopital Beaujon, INSERM U773 and University Paris-Diderot, Clichy, France, 10University of Auckland, Auckland, New Zealand

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif